The Sackler family, owners of Purdue Pharma, is preparing to defend against a series of opioid-related lawsuits by challenging the application of public nuisance laws. This legal strategy is pivotal as it counters the approach that has previously led to substantial settlements between pharmaceutical companies and communities affected by the opioid crisis. In response to ongoing litigation, attorneys for the Sacklers have revealed their defence plans in a recent court filing, part of the extensive bankruptcy proceedings involving Purdue Pharma. The family faces accusations of withdrawing billions of dollars from the company before its bankruptcy to shield assets from future claims, a charge they deny.

This development marks a significant phase in the legal battles surrounding the opioid epidemic, highlighting the complexities of holding pharmaceutical entities accountable. By disputing the applicability of public nuisance laws, the Sacklers aim to shift the narrative and potentially influence the outcomes of their cases. The resolution of these lawsuits could set precedents for similar cases, impacting how damages related to the opioid crisis are pursued in courts. For more information, visit Washington Post.